11361Judgment of the Court (First Chamber) of 27 June 2024.#Niche Generics Ltd v European Commission.#Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement.#Case C-164/19 P.cjeu_case · 27 июня 2024 г.
11362Judgment of the Court (First Chamber) of 27 June 2024.#European Commission v KRKA, tovarna zdravil, d.d.#Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Market sharing – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement – Patent licence agreement – Technology assignment and licence agreement.#Case C-151/19 P.cjeu_case · 27 июня 2024 г.
11363Judgment of the Court (First Chamber) of 27 June 2024.#Lupin Ltd v European Commission.#Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement.#Case C-144/19 P.cjeu_case · 27 июня 2024 г.
11364Case C-207/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Biogaran SAS v European Commission (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement – Licence and supply agreement)cjeu_case · 27 июня 2024 г.
11365Case C-201/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Servier SAS, Servier Laboratories Ltd, Les Laboratoires Servier SAS v European Commission, European Federation of Pharmaceutical Industries and Associations (EFPIA) (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement – Duration of the infringement – Concept of a single infringement – Annulment or reduction of the fine)cjeu_case · 27 июня 2024 г.
11366Case C-198/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Teva UK Ltd, Teva Pharmaceuticals Europe BV, Teva Pharmaceutical Industries Ltd v European Commission, European Generic medicines Association AISBL (EGA) (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement)cjeu_case · 27 июня 2024 г.
11367Case C-197/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Mylan Laboratories Ltd, Mylan Inc. v European Commission (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement)cjeu_case · 27 июня 2024 г.
11368Case C-176/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – European Commission v Servier SAS, Servier Laboratories Ltd, Les Laboratoires Servier, European Federation of Pharmaceutical Industries and Associations (EFPIA) (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Market sharing – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement – Patent licence agreement – Technology assignment and licence agreement – Article 102 TFEU – Relevant market – Abuse of dominant position)cjeu_case · 27 июня 2024 г.
11369Case C-166/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Unichem Laboratories Ltd v European Commission (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement)cjeu_case · 27 июня 2024 г.
11370Case C-164/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Niche Generics Ltd v European Commission (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement)cjeu_case · 27 июня 2024 г.
11371Case C-151/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – European Commission v KRKA, tovarna zdravil, d.d. (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Market sharing – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement – Patent licence agreement – Technology assignment and licence agreement)cjeu_case · 27 июня 2024 г.
11372Case C-144/19 P: Judgment of the Court (First Chamber) of 27 June 2024 – Lupin Ltd v European Commission (Appeal – Competition – Pharmaceutical products – Market for perindopril – Article 101 TFEU – Agreements, decisions and concerted practices – Potential competition – Restriction of competition by object – Strategy to delay the market entry of generic versions of perindopril – Patent dispute settlement agreement)cjeu_case · 27 июня 2024 г.
11374Case C-457/24 P: Appeal brought on 26 June 2024 by Romania against the judgment of the General Court (Tenth Chamber) delivered on 17 April 2024 in Case T-49/22 Romania v Commissioncjeu_case · 26 июня 2024 г.
11375CaseC-455/24 P: Appeal brought on 26 June 2024 by UC against the order of the General Court (Fourth Chamber) delivered on 17 April 2024 in Case T-6/23, UC v Councilcjeu_case · 26 июня 2024 г.
11376Case C-454/24 P: Appeal brought on 26 June 2024 by the Single Resolution Board against the judgment of the General Court (Eighth Chamber, Extended Composition) delivered on 10 April 2024 in Case T-411/22, SRB v Dexiacjeu_case · 26 июня 2024 г.
11377Case C-453/24, Hadenov: Request for a preliminary ruling from the Sofiyski gradski sad (Bulgaria) lodged on 26 June 2024 – Criminal proceedings against BCcjeu_case · 26 июня 2024 г.
11378Case C-452/24, Lunapark Scandinavia: Request for a preliminary ruling from the Korkein oikeus (Finland) lodged on 26 June 2024 – Oy Lunapark Scandinavia Ltd v Hardeco Finland Oycjeu_case · 26 июня 2024 г.
11379Case C-451/24, Kwizda Pharma II: Request for a preliminary ruling from the Verwaltungsgericht Wien (Austria) lodged on 26 June 2024 – Kwizda Pharma GmbHcjeu_case · 26 июня 2024 г.
11380Case C-449/24, DSE International: Request for a preliminary ruling from the Raad van State (Belgium) lodged on 26 June 2024 – DSE International BV v Belgische Staatcjeu_case · 26 июня 2024 г.